Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com -- Logista (BME:LOG) published its third-quarter 2025 results on Monday, showing figures that were largely in line with Bloomberg estimates.
The company reported economic sales of €445 million for the quarter, representing a 1% year-over-year decline. This figure was 1% below Bernstein’s forecast and 2% below the consensus based on five estimates.
Adjusted EBIT came in at €85 million in 3Q25, down 12% compared to the same period last year. This result was 2% above Bernstein’s forecast but 2% below consensus with two estimates.
Reported EBIT was €71 million, showing a 13% year-over-year decline, though this was 7% above Bernstein’s forecast.
Unlike previous quarters, Logista did not record any significant profit or loss on inventory in 3Q25. In comparison, the company had recorded +€14 million in 1Q25 and +€32 million in 2Q25, which had distorted figures and comparison bases in those periods.
Bernstein maintained a positive view on Logista, citing appreciation for the company’s resilient business model with defensive characteristics and high entry barriers. Bernstein also noted that Logista’s strong balance sheet and cash generation support external growth opportunities outside of tobacco.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.